Experimental Vaccine For Blood Cancer Cuts Death Risk By 41% In Trial: How Does It Work?

Experimental Vaccine For Blood Cancer Cuts Death Risk By 41% In Trial: How Does It Work?

Credit: AI image

Text

Updated Nov 18, 2026 | 09:34 AM IST

SummarySELLAS Life Sciences recently announced findings from their late-stage clinical trial in which they tested an experimental cancer vaccine for acute myeloid leukemia (AML).

End of Article